CME
CNE
Resources
News & Perspectives
Sign In or Register
Sign In
Forgot sign-in?
Create account
CME
CNE
Resources
News & Perspectives
Sign In or Register
Sign In
Forgot sign-in?
Create account
Free Online CME/CNE
All
Cardiology
Gastroenterology
Hematology
Immunotherapy
Oncology
Pain Medicine
Supportive Care
Targeted Therapy
Urology
New Clinical Perspectives in the Management of Myelofibrosis
1.0 CME | 1.0 MOC
In this online activity, Srdan Verstovsek, MD, PhD, explores predictive and prognostic markers for personalized care planning in myelofibrosis as well as emerging data in therapeutic strategies and the implications that research advances may have for future practice.
New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations
1.0 CME | 1.0 MOC | ILNA points
Watch this case-based CME-approved recording with Jamie E. Chaft, MD, as she discusses molecular and clinical factors that can inform first- and second-line treatment strategies for patients with NSCLC.
Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant
1.25 CME | 1.2 CNE | 1.25 MOC
In this case-based online activity, Miguel-Angel Perales, MD, discusses the graft-versus-leukemia effects of HSCT, emerging data on conditioning and maintenance therapies, and the management of transplant-related complications. Register today!
Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer
1.0 CME | 1.0 CNE | 1.0 MOC
Patients with TNBC have a poorer prognosis than those who present with HR-positive or HER2-positive disease. This CME/CE-approved discussion on metastatic TNBC with Sara Tolaney, MD, MPH and Sara Hurvitz, MD will evaluate personalized care plans, genetic risk evaluation, and novel therapies.
Current Standards and Best Practices in the Management of Tumor Lysis Syndrome
1.0 CME | 1.0 CNE | 1.0 MOC
This online strategy session features a multidisciplinary discussion between Anthony R. Mato, MD, MSCE and Colleen Dorsey, RN, BSN as they discuss risk for TLS, signs and symptoms, as well as prevention and treatment strategies in patients with hematologic malignancies.
Current Challenges and New Opportunities in Follicular Lymphoma
1.25 CME | 1.2 CNE | ILNA Points
Watch this case-based CME/CE-certified recording with Christopher R. Flowers, MD, MS as he discusses emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL.
Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies
1.0 CNE | ILNA Points
This online strategy session features a discussion between Stephanie Jackson, MSN, RN, AOCNS, BMTCN and Leslie Smith, RN, APRN-CNS, AOCNS on CAR T-cell therapy in patients with B-cell malignancies such as T-cell workflow, efficacy and safety data, as well as adverse event management.
Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia
1.0 CME | 1.0 CNE | 1.0 MOC
How can you improve the treatment outcomes for patients with this rare malignancy? This online activity, led by Morie A. Gertz, MD, MACP and Toni Dubeau, RN, NP, will discuss risk stratification, novel therapeutic approaches, and adverse event management. Start now!
Challenges and Opportunities in Hodgkin Lymphoma
1.0 CME | 1.0 CNE | 1.0 MOC
In this online activity, Craig H. Moskowitz, MD and Kami Maddocks, MD discuss factors that increase risk for cHL treatment failure, emerging data on the treatment of newly diagnosed and relapsed/refractory cHL, and assess strategies to manage toxicities associated with therapy.
Challenges and Opportunities in Metastatic Gastric Cancer
1.0 CME | 1.0 CNE | 1.0 MOC
This case-based discussion on metastatic gastric cancer features Jaffer A. Ajani, MD and Allyson J. Ocean, MD as they examine individualized treatment selection, novel therapies, and adverse event management. Register to get started today!
Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer
1.2 CNE | ILNA Points
This online CE-approved activity features a case-based discussion between Kathleen D. Burns, MSN, ANP, OCN® and Brenda Martone, MSN, ANP-BC, AOCNP® on combination and sequential treatment strategies, novel therapies, and adverse event management in CRPC.
Current Trends in the Management of Castration-Resistant Prostate Cancer
1.0 CME | 1.0 CNE | 1.0 MOC
In this case-based activity, Alicia K. Morgans, MD, MPH and Tanya Dorff, MD discuss predictive and prognostic markers, recent findings, novel treatments, and supportive care plans for patients with castration-resistant prostate cancer.
Nursing Management of Oral Mucositis
1.0 CNE | ILNA Points
Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions.
Nursing Management of Tumor Lysis Syndrome
1.0 CNE | ILNA Points
TLS is an oncological emergency which can result in acute renal failure, cardiac arrhythmias, seizures, and even death. This online activity reviews signs and symptoms, risk factors, and supportive care interventions.
Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy
1.0 CNE | ILNA Points
CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.
Nursing Management of Bone Health in Patients With Cancer
1.0 CNE | ILNA Points
Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbidity and mortality of bone complications in patients with cancer
Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer
1.0 CNE | ILNA Points
VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.
Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer
1.0 CNE | ILNA Points
VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews VTE pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.
Management of Cancer Pain: Current Guidelines
1.0 CNE | ILNA Points
Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.
Prevention of Medical Errors in Nursing Practice
1.0 CNE | ILNA Points
Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting.
Nursing Management of Cancer Treatment-Induced Cardiotoxicity
1.0 CNE | ILNA Points
Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of treatment-induced cardiotoxicity.
Free CME/CNE Live Meetings
New Directions in the Management of Relapsed/Refractory Follicular Lymphoma
1.0 CME | Visiting Professor Lecture Series
This case-based visiting professor lecture series will bring a leading clinical investigator to your cancer center to discuss personalized care planning and novel therapeutic approaches for relapsed/refractory FL. Schedule a meeting today!
Keeping Pace With Evolving Management Strategies in Castration-Resistant Prostate Cancer
1.0 CME | Satellite Symposium
This satellite symposium will feature an expert-led discussion on the mechanism of action and safety profiles for novel therapies as well as the sequential and combination treatment strategies for nonmetastatic and metastatic CRPC. Register for SGSU 2020!
New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations
1.0 CME | Visiting Faculty Meeting Series
Are you developing personalized care plans for your patients with advanced NSCLC? This activity will bring a leading clinical expert to your institution to discuss the use of molecular biomarkers to refine selection of novel therapies. Enroll your institution today!
Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The Nurse's View
1.0 CNE | Visiting Faculty Meeting Series
This case-based nursing activity will bring a leading clinical investigator to your institution to discuss tailored CRPC treatment plans, novel therapies, and adverse event management for metastatic and nonmetastatic CRPC. Schedule a meeting today!
Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant
1.0 CME/CNE | Visiting Faculty Meeting Series
This case-based activity will bring a clinical expert to your cancer center to evaluate emerging data that can optimize HSCT outcomes and strategies to manage transplant-related complications. Schedule a meeting at your institution today!
Evolving Treatment Paradigms in Multiple Myeloma and Implications for Shared Decision Making
1.0 CME/CNE/CPE | Visiting Faculty Meeting Series
This activity will bring a leading clinical investigator to your cancer center to discuss personalized care plans, novel therapies, and supportive care strategies for patients with MM. Schedule a meeting at your institution today!
New Clinical Perspectives in the Management of Myelofibrosis
1.0 CME | Visiting Faculty Meeting Series
This live meeting series will bring a leading clinical investigator to your institution to discuss predictive and prognostic markers, personalized care plans, emerging data, and research advances in the management of myelofibrosis. Request a meeting today!
Understanding Evolving Treatment Paradigms in Advanced Hepatocellular Carcinoma
1.0 CME/CNE | VA/DoD Meeting Series
This case-based activity will bring a leading clinical investigator to your VA/DoD medical center to discuss prognostic factors that can inform personalized care plans, novel therapies, and adverse event management. Schedule a meeting today!
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
1.0 CME/CNE/CPE | VA/DoD Meeting Series
This activity will discuss emerging efficacy and safety data on novel therapies for nmCRPC and mCRPC, strategies to manage adverse events, and the role of imaging studies and PSA testing in evaluating treatment response. Schedule a meeting today!
Company
About
Terms
Privacy
Site Map
Contact
Resources
i3 Health Education
i3 Health News & Perspectives
i3 Health Joint Providership Services
Follow Us
© Copyright 2019 i3 Health. All rights reserved.
